New FDA Approved Drug NATRECOR For Heart Failure Patients

The US government has approved a genetically engineered drug called NATRECOR to ease the breathing of hospitalized congestive heart failure patients. Congestive heart failure is a condition // in which the heart can't pump enough blood to meet the needs of the body's other organs. Most of the p...

Surveyed Experts Indicate that Biogen Idec's Adentri Has Advantages Over Nitroglycerin in the Treatment of Acute Heart Failure

...Resources' proprietary clinical gold standard for acute heart failure was Scios/Johnson & Johnson's Natrecor. Interviewed experts generally regard natrecor as being similarly efficacious as the benchmark therapy, nitroglycerin, but with a slightly better safety profile (e.g. fewer associated headaches). B...

United States Joins Suits Against Scios and Johnson & Johnson

...armaceutical Companies Allegedly Marketed the Drug natrecor for a Use Not Approved By the Food and Drug Admini...eging that the companies marketed the cardiac drug natrecor for a use not approved by the Food and Drug Admini...-label uses. In August 2001, the FDA approved natrecor for "the intravenous treatment of patients with ac...

Drugs from Biogen Idec and Merck are the Most Promising Therapies in Development in the Acute Heart Failure Market

...ck's rolofylline are the most promising therapies in development for acute heart failure, according to surveyed experts. Scios/Johnson & Johnson's natrecor and Daiichi Sankyo's Hanp have also added considerable value to the acute heart failure market in recent years and will continue to do so through 2017...

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

...ion for restructuring, an after-tax non-cash charge of $441 million for the natrecor intangible asset write-down, and a tax gain of $267 million associated with...ecial items related to an after-tax non-cash charge of $441 million for the natrecor asset write-down and a tax gain of $267 million associated with the restruc...

Study Supports Controversial Heart Failure Drug

...s hospitalized with heart failure. The study found natrecor to be safe when given to those patients it was dev...d that hospitalized heart failure patients who got natrecor (nesiritide) faced an 81 percent higher risk of dy...s admitted to a hospital with ADHF received either natrecor or a placebo within 12 hours of admission, for two...